Inflammatory hyperalgesia mediated by TRPV1, the pepper spray receptor in cornea

TRPV1(角膜中的胡椒喷雾受体)介导的炎症性痛觉过敏

基本信息

  • 批准号:
    7905402
  • 负责人:
  • 金额:
    $ 56.03万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-09-01 至 2011-09-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Chemical and thermal pain in the cornea is primarily transduced by a calcium- and sodium-permeable ion channel called TRPV1 expressed in nociceptors with cell bodies in the trigeminal ganglia. When injury (including surgery) or illness cause inflammation, the inflammatory process increases the sensitivity of TRPV1 ion channels to painful stimuli, a phenomenon known as inflammatory hyperalgesia. Our long-term goal is to understand the molecular mechanisms mediating inflammatory hyperalgesia, a critical first step in developing more effective pain therapies for corneal injury. In this study, we will focus on the molecular mechanisms of TRPV1 modulation by Nerve Growth Factor (NGF). Inflammation and injury lead to release of trophic factors such as NGF, insulin, and Insulin-like Growth Factor, which increase nociceptor excitability by activating receptor tyrosine kinases (RTKs). It has been proposed that RTK activation sensitizes TRPV1 through hydrolysis of phosphoinositide 4,5-bisphosphate (PIP2), relieving a tonic inhibition of TRPV1 by PIP2. The role of PIP2 is controversial, however, due to emerging evidence that phosphoinositide 3,4,5- trisphosphate (PIPS) may be involved. Based on our preliminary data, we propose that phosphorylation of PIP2 by phosphoinositide 3-kinase (PI3K) to form PIP3 may be an essential element of nociceptor sensitization by NGF. Our specific aims will address the molecular mechanism and functional significance of TRPV1 modulation by NGF. Understanding the regulation of TRPV1 by RTKs is critical to a complete understanding of how inflammation modulates corneal nociceptor excitability and to the development of improved therapies to treat inflammatory pain.
描述(申请人提供):角膜中的化学和热痛主要由一种名为TRPV1的钙和钠渗透离子通道传递,TRPV1表达于三叉神经节胞体的伤害性感受器中。当受伤(包括手术)或疾病引起炎症时,炎症过程会增加TRPV1离子通道对疼痛刺激的敏感性,这种现象被称为炎症性痛觉过敏。我们的长期目标是了解介导炎性痛觉过敏的分子机制,这是开发更有效的角膜损伤疼痛疗法的关键第一步。在本研究中,我们将重点研究神经生长因子(NGF)对TRPV1调控的分子机制。炎症和损伤导致NGF、胰岛素和胰岛素样生长因子等营养因子的释放,这些营养因子通过激活受体酪氨酸激酶(RTK)增加伤害性感受器的兴奋性。已有研究表明,RTK的激活通过4,5-二磷酸肌醇(PIP2)的水解使TRPV1增敏,解除了PIP2对TRPV1的紧张性抑制。然而,PIP2的作用存在争议,因为越来越多的证据表明,3,4,5-三磷酸(PIPS)可能参与了PIP2的作用。根据我们的初步数据,我们认为PIP2被磷脂酰肌醇3-激酶(PI3K)磷酸化形成PIP3可能是NGF对伤害性感受器增敏的一个重要因素。我们的具体目标是探讨NGF调节TRPV1的分子机制和功能意义。了解RTK对TRPV1的调节对于全面了解炎症如何调节角膜伤害性感受器的兴奋性以及开发改进的治疗炎症性疼痛的方法至关重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sharona E Gordon其他文献

Sharona E Gordon的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sharona E Gordon', 18)}}的其他基金

Conformational Energetics and Heterogeneity to Reveal Gating Mechanisms of TRPV and TRPM Ion Channels
构象能量学和异质性揭示 TRPV 和 TRPM 离子通道的门控机制
  • 批准号:
    10793400
  • 财政年份:
    2022
  • 资助金额:
    $ 56.03万
  • 项目类别:
Conformational Energetics and Heterogeneity to Reveal Gating Mechanisms of TRPV and TRPM Ion Channels
构象能量学和异质性揭示 TRPV 和 TRPM 离子通道的门控机制
  • 批准号:
    10627103
  • 财政年份:
    2022
  • 资助金额:
    $ 56.03万
  • 项目类别:
Conformational Energetics and Heterogeneity to Reveal Gating Mechanisms of TRPV and TRPM Ion Channels
构象能量学和异质性揭示 TRPV 和 TRPM 离子通道的门控机制
  • 批准号:
    10590571
  • 财政年份:
    2022
  • 资助金额:
    $ 56.03万
  • 项目类别:
Conformational Energetics and Heterogeneity to Reveal Gating Mechanisms of TRPV and TRPM Ion Channels
构象能量学和异质性揭示 TRPV 和 TRPM 离子通道的门控机制
  • 批准号:
    10404753
  • 财政年份:
    2022
  • 资助金额:
    $ 56.03万
  • 项目类别:
Conformational Energetics and Heterogeneity to Reveal Gating Mechanisms of TRPV and TRPM Ion Channels
构象能量学和异质性揭示 TRPV 和 TRPM 离子通道的门控机制
  • 批准号:
    10752849
  • 财政年份:
    2022
  • 资助金额:
    $ 56.03万
  • 项目类别:
Conformational Energetics and Heterogeneity to Reveal Gating Mechanisms of TRPV and TRPM Ion Channels
构象能量学和异质性揭示 TRPV 和 TRPM 离子通道的门控机制
  • 批准号:
    10728394
  • 财政年份:
    2022
  • 资助金额:
    $ 56.03万
  • 项目类别:
Conformational Energetics and Heterogeneity to Reveal Gating Mechanisms of TRPV and TRPM Ion Channels
构象能量学和异质性揭示 TRPV 和 TRPM 离子通道的门控机制
  • 批准号:
    10605108
  • 财政年份:
    2022
  • 资助金额:
    $ 56.03万
  • 项目类别:
Multimodal Gating Mechanisms of TRPV1 Ion Channels
TRPV1 离子通道的多模态门控机制
  • 批准号:
    10082453
  • 财政年份:
    2018
  • 资助金额:
    $ 56.03万
  • 项目类别:
Mechanisms of TRPV1 Channel Regulation
TRPV1通道调节机制
  • 批准号:
    8638032
  • 财政年份:
    2012
  • 资助金额:
    $ 56.03万
  • 项目类别:
Mechanisms of TRPV1 Channel Regulation
TRPV1通道调节机制
  • 批准号:
    8257782
  • 财政年份:
    2012
  • 资助金额:
    $ 56.03万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 56.03万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.03万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 56.03万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.03万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 56.03万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 56.03万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.03万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 56.03万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 56.03万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.03万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了